What are biologics and can the Trump administration make them cheaper with biosimilars?

What are biologics and can the Trump administration make them cheaper with biosimilars? Health Nov 19, 2025 5:03 PM EST

This article originally appeared on PolitiFact .

If you watch TV and don’t mute ads, you’ve probably heard of a few biologics. They’re drugs such as Humira for arthritis and Trulicity for Type 2 diabetes.

You may also know they are expensive. Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s total prescription medicine spending, according to health data analysis company IQVIA.

The Trump administration said it hopes to make these medications more affordable partly by increasing access to “biosimilars,” or highly similar products. What are biologics and biosimilars and will the administ